Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease.

Chen Y, Tian Z, Liang Z, Sun S, Dai CL, Lee MH, LaFerla FM, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

PLoS One. 2012;7(12):e51432. doi: 10.1371/journal.pone.0051432. Epub 2012 Dec 7.

PMID:
23236499
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).

Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

Mol Neurobiol. 2013 Apr;47(2):711-25. doi: 10.1007/s12035-012-8375-5. Epub 2012 Nov 14.

PMID:
23150171
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.

Wu ZL, Ciallella JR, Flood DG, O'Kane TM, Bozyczko-Coyne D, Savage MJ.

Neurobiol Aging. 2006 Mar;27(3):377-86. Epub 2005 May 31.

PMID:
15927307
[PubMed - indexed for MEDLINE]
4.

Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.

Guzmán EA, Bouter Y, Richard BC, Lannfelt L, Ingelsson M, Paetau A, Verkkoniemi-Ahola A, Wirths O, Bayer TA.

Mol Neurodegener. 2014 Apr 2;9:13. doi: 10.1186/1750-1326-9-13.

PMID:
24694184
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.

Pedrós I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas-Zarate C, Auladell C, Pallàs M, Vázquez-Carrera M, Casadesús G, Folch J, Camins A.

Biochim Biophys Acta. 2014 Sep;1842(9):1556-66. doi: 10.1016/j.bbadis.2014.05.025. Epub 2014 Jun 2.

PMID:
24887203
[PubMed - indexed for MEDLINE]
6.

Early and sustained altered expression of aging-related genes in young 3xTg-AD mice.

Gatta V, D'Aurora M, Granzotto A, Stuppia L, Sensi SL.

Cell Death Dis. 2014 Feb 13;5:e1054. doi: 10.1038/cddis.2014.11.

PMID:
24525730
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.

Giuliani D, Ottani A, Zaffe D, Galantucci M, Strinati F, Lodi R, Guarini S.

Neurobiol Learn Mem. 2013 Sep;104:82-91. doi: 10.1016/j.nlm.2013.05.006. Epub 2013 May 31.

PMID:
23726868
[PubMed - indexed for MEDLINE]
8.

Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice.

Chen Y, Liang Z, Tian Z, Blanchard J, Dai CL, Chalbot S, Iqbal K, Liu F, Gong CX.

Mol Neurobiol. 2014 Feb;49(1):547-62. doi: 10.1007/s12035-013-8539-y. Epub 2013 Aug 31.

PMID:
23996345
[PubMed - indexed for MEDLINE]
9.

Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin.

Lee Y, Kim YH, Park SJ, Huh JW, Kim SH, Kim SU, Kim JS, Jeong KJ, Lee KM, Hong Y, Lee SR, Chang KT.

J Alzheimers Dis. 2014;38(2):251-67. doi: 10.3233/JAD-130776.

PMID:
23948941
[PubMed - indexed for MEDLINE]
10.

Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models.

Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J.

Brain Res. 2010 Aug 6;1347:179-85. doi: 10.1016/j.brainres.2010.05.084.

PMID:
20677372
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease.

Devi L, Alldred MJ, Ginsberg SD, Ohno M.

PLoS One. 2012;7(3):e32792. doi: 10.1371/journal.pone.0032792. Epub 2012 Mar 5.

PMID:
22403710
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease.

Trushina E, Nemutlu E, Zhang S, Christensen T, Camp J, Mesa J, Siddiqui A, Tamura Y, Sesaki H, Wengenack TM, Dzeja PP, Poduslo JF.

PLoS One. 2012;7(2):e32737. doi: 10.1371/journal.pone.0032737. Epub 2012 Feb 29.

PMID:
22393443
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease.

Walker MP, LaFerla FM, Oddo SS, Brewer GJ.

Age (Dordr). 2013 Jun;35(3):519-31. doi: 10.1007/s11357-011-9375-5. Epub 2012 Jan 12.

PMID:
22237558
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Quantitative Expression Analysis of APP Pathway and Tau Phosphorylation-Related Genes in the ICV STZ-Induced Non-Human Primate Model of Sporadic Alzheimer's Disease.

Park SJ, Kim YH, Nam GH, Choe SH, Lee SR, Kim SU, Kim JS, Sim BW, Song BS, Jeong KJ, Lee Y, Park YI, Lee KM, Huh JW, Chang KT.

Int J Mol Sci. 2015 Jan 22;16(2):2386-402. doi: 10.3390/ijms16022386.

PMID:
25622254
[PubMed - in process]
Free Article
15.

Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.

Shilling D, Müller M, Takano H, Mak DO, Abel T, Coulter DA, Foskett JK.

J Neurosci. 2014 May 14;34(20):6910-23. doi: 10.1523/JNEUROSCI.5441-13.2014.

PMID:
24828645
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.

Chigurupati S, Madan M, Okun E, Wei Z, Pattisapu JV, Mughal MR, Mattson MP, Chan SL.

J Alzheimers Dis. 2011;24(2):349-61. doi: 10.3233/JAD-2011-101797.

PMID:
21258150
[PubMed - indexed for MEDLINE]
17.

High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.

Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.

Neuroscience. 2009 Mar 3;159(1):296-307. doi: 10.1016/j.neuroscience.2008.12.006. Epub 2008 Dec 14.

PMID:
19135506
[PubMed - indexed for MEDLINE]
18.

REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.

Orta-Salazar E, Aguilar-Vázquez A, Martínez-Coria H, Luquín-De Anda S, Rivera-Cervantes M, Beas-Zarate C, Feria-Velasco A, Díaz-Cintra S.

Life Sci. 2014 Oct 29;116(2):83-9. doi: 10.1016/j.lfs.2014.09.013. Epub 2014 Sep 28.

PMID:
25261598
[PubMed - in process]
19.

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.

Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S.

J Alzheimers Dis. 2010;19(2):691-704. doi: 10.3233/JAD-2010-1270.

PMID:
20110613
[PubMed - indexed for MEDLINE]
20.

Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.

Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, Scott RW, Flood DG.

J Neurosci. 2000 Dec 1;20(23):8717-26.

PMID:
11102478
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk